More than 50 cancer organizations to issue a call to action urging individuals, providers, and insurers to increase access to and utilization of low-dose CT scans for those at high risk for lung cancer.
The FY24 Defense Appropriations Act provides funding for the LCRP to support innovative, high-impact lung cancer research. The managing agent for the anticipated funding opportunities is the CDMRP at the U.S. Army Medical Research and Development Command.
